Reck M, Dziadziuszko R, Sugawara S, Kao S, et al. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study. Lung Cancer 2024;196:107924.
PMID: 39306923